A protocol for generating high numbers of mature and functional human mast cells from peripheral blood

Clinical and Experimental Allergy

Volumn 37, Issue 9, 2007, Pages 1404-1414

  Lappalainen, J ^a   Lindstedt, K A ^a   Kovanen, P T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

Chymase; Differentiation; Histamine; In vitro; Mast cells; Tryptase

Indexed keywords

CATHEPSIN G; CHYMASE; COMPLEMENT COMPONENT C3A; CYTOKINE; EPSILON OPIATE RECEPTOR; FC EPSILON RECEPTOR I; HEPARIN; HISTAMINE; IMMUNOGLOBULIN E; STEM CELL FACTOR RECEPTOR; TRYPTASE; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; CD34 SELECTION; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; INNATE IMMUNITY; MAST CELL; METHODOLOGY; PERIPHERAL CIRCULATION; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

BLOOD CELLS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MAST CELLS; STEM CELL FACTOR;

EID: 34548493711     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02778.x     Document Type: Article

References (66)

1. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005 23 : 749 86.
2. Clejan S, Japa S, Clemetson C, Hasabnis SS, David O, Talano JV. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J Cell Mol Med 2002 6 : 583 92.
3. Kaartinen M, Penttilä A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994 90 : 1669 78.
4. Woolley DE. The mast cell in inflammatory arthritis. N Engl J Med 2003 348 : 1709 11.
5. Schwartz LB. Mast cells: function and contents. Curr Opin Immunol 1994 6 : 91 7.
6. Kempuraj D, Saito H, Kaneko A et al. Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood 1999 93 : 3338 46.
7. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997 77 : 1033 79.
8. Metcalfe DD, Lewis RA, Silbert JE, Rosenberg RD, Wasserman SI, Austen KF. Isolation and characterization of heparin from human lung. J Clin Invest 1979 64 : 1537 43.
9. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 1999 94 : 2333 42.
10. Irani AM, Nilsson G, Miettinen U et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 1992 80 : 3009 21.
11. Kitamura Y, Yokoyama M, Matsuda H, Ohno T, Mori KJ. Spleen colony-forming cell as common precursor for tissue mast cells and granulocytes. Nature 1981 291 : 159 60.
12. Valent P, Spanblochl E, Sperr WR et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term culture. Blood 1992 80 : 2237 45.
13. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD. Demonstration of the origin of human mast cells from CD34+bone marrow progenitor cells. J Immunol 1991 146 : 1410 5.
14. Yanagida M, Fukamachi H, Ohgami K et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood 1995 86 : 3705 14.
15. Akin C, Brockow K, D'Ambrosio C et al. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. Exp Hematol 2003 31 : 686 92.
16. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 1978 52 : 447 52.
17. Costa JJ, Demetri GD, Harrist TJ et al. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996 183 : 2681 6.
18. Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+pluripotent progenitor cells. J Immunol 1992 148 : 772 7.
19. Gebhardt T, Sellge G, Lorentz A, Raab R, Manns MP, Bischoff SC. Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release. Eur J Immunol 2002 32 : 2308 16.
20. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 1999 190 : 267 80.
21. Kulka M, Metcalfe DD. High-resolution tracking of cell division demonstrates differential effects of TH1 and TH2 cytokines on SCF-dependent human mast cell production in vitro: correlation with apoptosis and kit expression. Blood 2005 105 : 592 9.
22. Matsuzawa S, Sakashita K, Kinoshita T, Ito S, Yamashita T, Koike K. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol 2003 170 : 3461 7.
23. Schulman ES, MacGlashan DW Jr., Peters SP, Schleimer RP, Newball HH, Lichtenstein LM. Human lung mast cells: purification and characterization. J Immunol 1982 129 : 2662 7.
24. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988 12 : 345 55.
25. Kirshenbaum AS, Akin C, Wu Y et al. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 2003 27 : 677 82.
26. Jensen BM, Dissing S, Skov PS, Poulsen LK. A comparative study of the FcepsilonRI molecule on human mast cell and basophil cell lines. Int Arch Allergy Immunol 2005 137 : 93 103.
27. Saito H, Ebisawa M, Tachimoto H et al. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996 157 : 343 50.
28. Mitsui H, Furitsu T, Dvorak AM et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 1993 90 : 735 9.
29. Kinoshita T, Sawai N, Hidaka E, Yamashita T, Koike K. Interleukin-6 directly modulates stem cell factor-dependent development of human mast cells derived from CD34(+) cord blood cells. Blood 1999 94 : 496 508.
30. Rottem M, Okada T, Goff JP, Metcalfe DD. Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/Fc epsilon RI- cell population. Blood 1994 84 : 2489 96.
31. Kambe N, Kambe M, Chang HW et al. An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium. J Immunol Methods 2000 240 : 101 10.
32. Dahl C, Saito H, Nielsen HV, Schiotz PO. The establishment of a combined serum-free and serum-supplemented culture method of obtaining functional cord blood-derived human mast cells. J Immunol Methods 2002 262 : 137 43.
33. Wang XS, Yip KH, Sam SW, Lau HY. Buffy coat preparation is a convenient source of progenitors for culturing mature human mast cells. J Immunol Methods 2006 309 : 69 74.
34. Kokkonen JO, Kovanen PT. Low density lipoprotein degradation by rat mast cells. Demonstration of extracellular proteolysis caused by mast cell granules. J Biol Chem 1985 260 : 14756 63.
35. Schwartz LB, Bradford TR, Rouse C et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994 14 : 190 204.
36. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986 883 : 173 7.
37. Shore PA, Burkhalter A, Cohn VH Jr. A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 1959 127 : 182 6.
38. Sawai N, Koike K, Mwamtemi HH et al. Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoietic progenitors. Blood 1999 93 : 3703 12.
39. Bodger MP, Mounsey GL, Nelson J, Fitzgerald PH. A monoclonal antibody reacting with human basophils. Blood 1987 69 : 1414 8.
40. Valent P, Majdic O, Maurer D, Bodger M, Muhm M, Bettelheim P. Further characterization of surface membrane structures expressed on human basophils and mast cells. Int Arch Allergy Appl Immunol 1990 91 : 198 203.
41. Schwartz LB. Analysis of MC(T) and MC(TC) mast cells in tissue. Methods Mol Biol 2006 315 : 53 62.
42. Shimizu Y, Sakai K, Miura T et al. Characterization of 'adult-type' mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymase, and CD13 expression is reduced during differentiation. Clin Exp Allergy 2002 32 : 872 80.
43. Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM. A functional comparison of CD34+CD38-cells in cord blood and bone marrow. Blood 1995 86 : 3745 53.
44. Iida M, Matsumoto K, Tomita H et al. Selective down-regulation of high-affinity IgE receptor (Fc epsilon RI) alpha-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood 2001 97 : 1016 22.
45. Nomura I, Katsunuma T, Matsumoto K et al. Human mast cell progenitors in peripheral blood from atopic subjects with high IgE levels. Clin Exp Allergy 2001 31 : 1424 31.
46. Inomata N, Tomita H, Ikezawa Z, Saito H. Differential gene expression profile between cord blood progenitor-derived and adult progenitor-derived human mast cells. Immunol Lett 2005 98 : 265 71.
47. Ivanovic Z, Hermitte F, de la Grange PB et al. Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%). Stem Cells 2004 22 : 716 24.
48. Koller MR, Bender JG, Papoutsakis ET, Miller WM. Beneficial effects of reduced oxygen tension and perfusion in long-term hematopoietic cultures. Ann NY Acad Sci 1992 665 : 105 16.
49. Ishida S, Kinoshita T, Sugawara N, Yamashita T, Koike K. Serum inhibitors for human mast cell growth: possible role of retinol. Allergy 2003 58 : 1044 52.
50. Saito H, Kempuraj D, Tomikawa M, Tomita H, Ahn K, Iikura Y. Human mast cell colony-forming cells in culture. Int Arch Allergy Immunol 2001 124 : 301 3.
51. Ahn K, Takai S, Pawankar R et al. Regulation of chymase production in human mast cell progenitors. J Allergy Clin Immunol 2000 106 : 321 8.
52. Schernthaner GH, Hauswirth AW, Baghestanian M et al. Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors. Allergy 2005 60 : 1248 55.
53. Saito H, Hatake K, Dvorak AM et al. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci USA 1988 85 : 2288 92.
54. Valent P, Schmidt G, Besemer J et al. Interleukin-3 is a differentiation factor for human basophils. Blood 1989 73 : 1763 9.
55. Oskeritzian CA, Wang Z, Kochan JP et al. Recombinant human (rh IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors. J Immunol 1999 163 : 5105 15.
56. Toru H, Ra C, Nonoyama S, Suzuki K, Yata J, Nakahata T. Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4. Int Immunol 1996 8 : 1367 73.
57. Ochi H, De Jesus NH, Hsieh FH, Austen KF, Boyce JA. IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production. Proc Natl Acad Sci USA 2000 97 : 10509 13.
58. Lorentz A, Wilke M, Sellge G et al. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 2005 174 : 6751 6.
59. Toru H, Eguchi M, Matsumoto R, Yanagida M, Yata J, Nakahata T. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation. Blood 1998 91 : 187 95.
60. Shimizu Y, Suga T, Maeno T et al. Detection of tryptase-, chymase+ cells in human CD34 bone marrow progenitors. Clin Exp Allergy 2004 34 : 1719 24.
61. Dvorak AM. Ultrastructure of human mast cells. Int Arch Allergy Immunol 2002 127 : 100 5.
62. Thompson HL, Schulman ES, Metcalfe DD. Identification of chondroitin sulfate E in human lung mast cells. J Immunol 1988 140 : 2708 13.
63. Lindstedt KA, Kokkonen JO, Kovanen PT. Regulation of the activity of secreted human lung mast cell tryptase by mast cell proteoglycans. Biochim Biophys Acta 1998 1425 : 617 27.
64. Nilsson G, Blom T, Harvima I, Kusche-Gullberg M, Nilsson K, Hellman L. Stem cell factor-dependent human cord blood derived mast cells express alpha- and beta-tryptase, heparin and chondroitin sulphate. Immunology 1996 88 : 308 14.
65. Church MK, Pao GJ, Holgate ST. Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol 1982 129 : 2116 21.
66. Benyon RC, Lowman MA, Church MK. Human skin mast cells: their dispersion, purification, and secretory characterization. J Immunol 1987 138 : 861 7.